David Ryan
Fortuna: - $ al 31/07/2026
Fortuna: - $ al 31/07/2026
David P.
Ryan currently works at MPM BioImpact LLC, as Advisor.
Dr. Ryan also formerly worked at Cullinan Therapeutics, Inc., as Independent Director from 2022 to 2025.
Dr. Ryan received his doctorate degree from Columbia University Vagelos College of Physicians & Surgeons.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/06/2025 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Consultor / Asesor | - |
| Empresas | Cargo | Fin |
|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Director/Miembro de la Junta | 07/08/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Columbia University Vagelos College of Physicians & Surgeons
Columbia University Vagelos College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cullinan Oncology, Inc.
Cullinan Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.